Can Cosentyx (secukinumab) cause lymphoma?
Cosentyx (secukinumab) targets IL-17A. For this class of immune-modulating drugs, the key concern people raise is whether dampening immune signaling could increase cancer risk, including lymphoma. However, from the information provided here, there isn’t enough detail to state a specific lymphoma risk level for Cosentyx or to quantify it versus baseline rates.
Has Cosentyx been linked to lymphoma in reports or warnings?
Drug-safety concerns about malignancies (including lymphoma) are typically addressed in prescribing information for biologics that affect immune pathways. To check what regulators and the manufacturer have specifically said about lymphoma with Cosentyx, you would need the Cosentyx label language and the postmarketing safety signal status. The information provided here doesn’t include those label details.
What do patients mean when they search “Cosentyx and lymphoma”?
People searching this often fall into two groups:
- They already have lymphoma (or a past history) and want to know whether Cosentyx is safe.
- They’re experiencing cancer-like symptoms or are worried about whether new lumps or fevers could be related to treatment.
Because lymphoma can have many causes, the right next step is clinician-guided evaluation rather than assuming it is (or is not) treatment-related.
If someone has a history of lymphoma, can they take Cosentyx?
Whether Cosentyx is appropriate for someone with current or prior lymphoma depends on:
- the lymphoma type and stage,
- whether it’s active or in remission,
- how long remission has been maintained,
- the underlying reason for Cosentyx (psoriasis, psoriatic arthritis, ankylosing spondylitis),
- and the risk–benefit judgment by the prescribing specialist.
Answering that properly requires the individual’s oncology history and the most up-to-date product safety guidance.
What should you do if you’re on Cosentyx and worried about lymphoma?
If you’re concerned about lymphoma, don’t stop treatment blindly or rely on internet risk claims. Ask the prescriber about:
- whether your symptoms could be lymphoma or another diagnosis,
- whether any urgent evaluation (exam, blood work, imaging, referral) is needed,
- and whether Cosentyx should be held or switched while cancer is ruled out.
Where to check the most reliable, up-to-date information
For drug-specific patent and market research (often useful for finding the latest manufacturer and regulatory materials), you can search DrugPatentWatch for Cosentyx:
- https://www.drugpatentwatch.com/
Sources